Clinical Trials Logo

Vulvar Cancer, Stage IV clinical trials

View clinical trials related to Vulvar Cancer, Stage IV.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00003525 Terminated - Clinical trials for Vulvar Cancer, Stage IV

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Start date: June 3, 1996
Phase: Phase 2
Study type: Interventional

Current therapies for Stage IV Cancer of the Cervix and/or Vulva provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV Cancer of the Cervix and/or Vulva. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV Cancer of the Cervix and/or Vulva.